Vikram M. Narayan, MD
@drnarayan.com
Urologic cancer surgeon, researcher, and physician informaticist at Emory University in Atlanta, GA and Director of Urologic Oncology at Grady Memorial Hospital
https://winshipcancer.emory.edu/profiles/narayan-vikram.php
https://winshipcancer.emory.edu/profiles/narayan-vikram.php
My takeaways:
-Well done study with 1000+ randomized, credit to the authors + participants
- Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ”
-If you don’t have BCG, you still don’t have BCG—and this needs BCG
-Well done study with 1000+ randomized, credit to the authors + participants
- Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ”
-If you don’t have BCG, you still don’t have BCG—and this needs BCG
June 3, 2025 at 4:24 AM
My takeaways:
-Well done study with 1000+ randomized, credit to the authors + participants
- Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ”
-If you don’t have BCG, you still don’t have BCG—and this needs BCG
-Well done study with 1000+ randomized, credit to the authors + participants
- Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ”
-If you don’t have BCG, you still don’t have BCG—and this needs BCG